Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
11/24/2004 | CN1549822A Methylene-4-azasteroids |
11/24/2004 | CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists |
11/24/2004 | CN1549812A Pyrazole compounds useful as protein kinase inhibitors. |
11/24/2004 | CN1549803A 维生素d的类似物 Analogs of vitamin d |
11/24/2004 | CN1549734A Aromatase inhibition to enhance assisted reproduction |
11/24/2004 | CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
11/24/2004 | CN1549703A 药物输送体系 Drug delivery system |
11/23/2004 | US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders |
11/23/2004 | US6821984 Ring fused pyrazole derivatives as CRF antagonists |
11/23/2004 | CA2171329C Androstenones |
11/23/2004 | CA2059052C Phenylimidazolidines, process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
11/18/2004 | WO2004099395A2 A method for the generation of neural progenitor cells |
11/18/2004 | WO2004099122A2 Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
11/18/2004 | WO2004098646A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
11/18/2004 | WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents |
11/18/2004 | WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
11/18/2004 | US20040229932 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor |
11/18/2004 | US20040229912 Polymeric delivery formulations of leuprolide with improved efficacy |
11/18/2004 | US20040229899 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) |
11/18/2004 | US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists |
11/18/2004 | US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract |
11/18/2004 | US20040229870 Certain alkylene diamine-substituted heterocycles |
11/18/2004 | US20040229869 For prophylaxis and therapy of medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma |
11/18/2004 | US20040229823 For use in therapy of growth metabolic disorders |
11/18/2004 | CA2524474A1 Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
11/18/2004 | CA2523712A1 Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
11/17/2004 | EP1477483A1 Vitamin d3 derivatives and remedies using the same |
11/17/2004 | EP1477178A2 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
11/17/2004 | EP1476470A1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
11/17/2004 | EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b |
11/17/2004 | EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
11/17/2004 | EP1476165A1 Substituted pyrimidinones and pyrimidinthiones |
11/17/2004 | EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors |
11/17/2004 | EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
11/17/2004 | EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
11/17/2004 | EP1171120A4 Methods for alleviating discomfort of a hot flash and compositions therefor |
11/17/2004 | EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection |
11/17/2004 | EP1144409B1 Phenyl urea and phenyl thiourea derivatives |
11/17/2004 | EP1137667B1 Analogues of glp-1 |
11/17/2004 | EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use |
11/17/2004 | EP0731811B1 Chaperonin 10 |
11/17/2004 | CN1175827C Health-care Chinese traditional medicine, and method for preparing same |
11/16/2004 | US6818638 Melvinolin derivatives |
11/16/2004 | US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
11/11/2004 | WO2004096851A1 Galectin 9-inducing factor |
11/11/2004 | WO2004096265A1 Nutrient liquid containing human growth hormone and the preparation method thereof |
11/11/2004 | WO2004096250A1 Blood sugar regulating agent comprising a natural dry product derived from soya bean seeds alone or in a mixture and preparation thereof |
11/11/2004 | WO2004096240A1 Anthocyanins useful for the treatment of diabetes, cardiovascular disorders and to lower the risk of adverse effects of hormone replacement therapy |
11/11/2004 | WO2004096198A1 Therapeutic agent |
11/11/2004 | WO2004096118A2 Composition for improving cognition and memory |
11/11/2004 | WO2004072044A3 Urea and thiourea derivatives |
11/11/2004 | WO2004028516A3 Compositions for the inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases |
11/11/2004 | WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance |
11/11/2004 | US20040225139 a 3-oxo-androstrane carbothioic acid compound |
11/11/2004 | US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
11/11/2004 | US20040225123 Substituted phenyl naphthalenes as estrogenic agents |
11/11/2004 | US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
11/11/2004 | US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
11/11/2004 | US20040224985 for controlling weight; pyrrolidine or piperidine compounds |
11/11/2004 | US20040224934 3 -oxo-androstrane carbothioic acid compound |
11/11/2004 | US20040224932 crystal structure; antiinflammatory agents; antiallergens |
11/11/2004 | US20040224931 3-oxo-androstrane carbothioic acid compound |
11/11/2004 | US20040224929 Novel vitamin D analogs |
11/11/2004 | US20040224911 Transporters and ion channels |
11/11/2004 | US20040224314 G-protein coupled receptors |
11/11/2004 | US20040224018 labile agent such as human growth hormone complexed with zinc for example; wet milling suspension of labile agent dispersed in biocompatible polymer and solvent to submicron particles of labile agent; drying to form solid polymer/labile agent matrix; sustained release formulation |
11/11/2004 | DE10317528A1 Production of calystegines for use as glycosidase inhibitors in treating diseases such as cancer, viral infections and diabetes, comprises extraction from the leaves of Solanaceae plants |
11/11/2004 | CA2562863A1 Blood sugar regulating agent comprising a natural dry product derived from soya bean seeds alone or in a mixture and preparation thereof |
11/11/2004 | CA2523508A1 Galectin 9-inducing factors |
11/10/2004 | EP1474445A1 Glycoisoforms of adiponectin and uses thereof |
11/10/2004 | EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
11/10/2004 | EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents |
11/10/2004 | EP1474122A2 Compounds for blocking androgen receptors |
11/10/2004 | EP1474119A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta |
11/10/2004 | EP1474103A1 Levothyroxine compositions and methods |
11/10/2004 | EP1474093A2 Granzyme b inhibitors |
11/10/2004 | EP1280803B1 Crystalline form ii of cabergoline |
11/10/2004 | EP0975348B1 Stabilized tibolone compositions |
11/10/2004 | CN1545415A Bone anabolic compounds and methods of use |
11/10/2004 | CN1545408A Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
11/10/2004 | CN1174969C New preparation method for N-(1, 1-dimethyl ethide)-4-[[(5'-oxethyl-4-cis-[2-(4-morpholino) oxethyl]-2'-oxo ancylus [cyclohexane-1, 3'-[3H] indole]-1'(2'H) group)-sulfonyl]-3-methoxyl benzamide and it |
11/10/2004 | CN1174964C Vitamin D3 Analogs |
11/09/2004 | US6815534 Tissue plasminogen activator-like protease |
11/09/2004 | US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester |
11/09/2004 | US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
11/09/2004 | US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
11/09/2004 | US6815438 Heteroaryl-diazabicycloalkanes |
11/09/2004 | US6814976 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience |
11/04/2004 | WO2004093882A1 Remedies for diseases to be applied to eye |
11/04/2004 | WO2004093857A1 Composition for relieving unpleasant symptoms accompanying change in protesterone |
11/04/2004 | WO2004093781A2 Podophyllotoxin derivatives as igf-1r inhibitors |
11/04/2004 | WO2003077847A3 Substituted amides |
11/04/2004 | WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
11/04/2004 | US20040220238 Pyrrolidine oxadiazole-and thiadiazole derivatives |
11/04/2004 | US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
11/04/2004 | US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders |
11/04/2004 | US20040220157 a 3-oxoandrostrane carbothioic acid compound |
11/04/2004 | US20040220147 Antiarrhythmia agents; liver disorders; skin disorders |
11/04/2004 | US20040220116 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds, |
11/04/2004 | US20040220092 G-protein coupled receptors |